Mapping the genetic blueprint of breast cancer in russia
NCT ID NCT05939128
Summary
This study aims to understand how common BRCA gene mutations are in Russian patients with high-risk, early-stage breast cancer that is HER2-negative. It will observe 625 patients to see how these genetic factors relate to the treatments they receive and their long-term health outcomes. The goal is to gather knowledge to potentially improve future care, but it does not test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Arkhangelsk, Russia
-
Research Site
Barnaul, Russia
-
Research Site
Belgorod, Russia
-
Research Site
Chelyabinsk, Russia
-
Research Site
Grozny, Russia
-
Research Site
Irkutsk, Russia
-
Research Site
Khanty-Mansiysk, Russia
-
Research Site
Krasnodar, Russia
-
Research Site
Krasnoyarsk, Russia
-
Research Site
Moscow, Russia
-
Research Site
Nal'chik, Russia
-
Research Site
Nyzhny Novgorod, Russia
-
Research Site
Ryazan, Russia
-
Research Site
Saint Petersburg, Russia
-
Research Site
Severodvinsk, Russia
-
Research Site
Sochi, Russia
-
Research Site
Ufa, Russia
-
Research Site
Vladivostok, Russia
-
Research Site
Yaroslavl, Russia
Conditions
Explore the condition pages connected to this study.